Capital expenditure decreased 99.8%
Capital expenditure changed -99.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Capital expenditure changed -99.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Current liabilities changed -37.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Trade receivables changed +185.9% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Current assets changed -39.4% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Working capital changed -39.7% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Operating income changed +46.7% from the comparable as-filed period.
Operating margin changed +9356 basis points from the comparable as-filed period.
Shares outstanding changed +15.1% from the comparable as-filed period. The change ranks at the 88th percentile of 8 prior comparable changes.
Free-cash-flow proxy changed +20.5% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Operating cash flow changed +19.4% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Revenue changed -43.8% from the comparable as-filed period.
Research & development changed -31.6% from the comparable as-filed period.
Total assets changed -35.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Capex / revenue changed -1561 basis points from the comparable as-filed period.
SBC / revenue changed +4792 basis points from the comparable as-filed period.
Stock-based compensation changed -20.8% from the comparable as-filed period.
Cash & equivalents changed +3.9% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Working capital / assets changed -499 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Free-cash-flow margin changed -44500 basis points from the comparable as-filed period.
Operating cash-flow margin changed -46060 basis points from the comparable as-filed period.
R&D / revenue changed +22532 basis points from the comparable as-filed period.
Receivables / revenue changed +1088 basis points from the comparable as-filed period.
Current ratio changed -2.7% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.